Stephens & Co. Maintains Equal-Weight on Treace Medical Concepts, Lowers Price Target to $25
Portfolio Pulse from jenniferd'souza@benzinga.com
Stephens & Co. analyst George Sellers maintains an Equal-Weight rating on Treace Medical Concepts (NASDAQ:TMCI) and lowers the price target from $27 to $25.
August 10, 2023 | 2:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stephens & Co. has maintained an Equal-Weight rating on Treace Medical Concepts and lowered the price target from $27 to $25.
The lowering of the price target by Stephens & Co. indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on TMCI's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100